Targeted Weight Loss Program with GLP-1 Medication to Help Prevent Joint Replacement and Improve Surgical Outcomes
At the practice of Dr. Joseph Mitchell, we are committed to providing our patients with innovative, whole-person care, not just treating joint pain, but also addressing the root causes behind it.
As part of this mission, we offer a medically guided weight loss program that includes GLP-1 medications (such as semaglutide and tirzepatide). These FDA-approved medications have shown significant success in helping patients lose weight safely and effectively.
Why It Matters
Excess body weight is a major contributor to joint degeneration, especially in the hips and knees. Carrying extra weight increases pressure on the joints, accelerates cartilage breakdown, and increases inflammation, often leading to the need for joint replacement surgery.
But it doesn’t stop there. Patients with obesity are also at a higher risk of complications after joint replacement surgery, including:
- Infection
- Delayed healing
- Implant failure
How This Program Helps:
Our GLP-1–based weight loss program is designed to:
- Help prevent or delay the need for joint replacement in some patients
- Reduce complications in those who do require surgery
- Support sustainable weight loss with medical supervision
- Improve overall joint function, mobility, and quality of life
Personalized Care for Better Outcomes
Dr. Mitchell collaborates with patients to create individualized treatment plans. If you’re dealing with joint pain and excess weight, this program may be the first step toward long-term relief, with or without surgery.
To find out if you’re a candidate for our GLP-1 weight loss program, please call or click here to request an appointment online.